IDV vehicle
36E79723D0006
10 LINE ITEMS FOR DOXEPIN CAPSULES. AWARDED FOR BASE YEAR 2/19/2023 TO 2/18/2024 PLUS 4 ONE-YEAR OPTIONS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $5.8M |
| Start date | Feb 19, 2023 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 10, 2026 | P00008 | $0 | THIS MODIFICATION INCORPORATES SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026), INTO EXISTING NATIONAL CONTRACT 36E79724D0006. |
| Dec 17, 2025 | P00007 | $0 | EXERCISING 3RD OPTION YEAR FOR DOXEPIN CAPSULES UNDER CONTRACT 36E79723D0006 FIRST NATION GROUP, LLC. WITH NO PRICE CHANGES |
| Jan 24, 2025 | P00006 | $0 | EXERCISING 2ND OPTION YEAR FOR DOXEPIN CAPSULES UNDER CONTRACT 36E79723D0006 FIRST NATION GROUP, LLC. WITH NO PRICES |
| Nov 20, 2024 | P00005 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A COMPANY NAME CHANGE. |
| Apr 23, 2024 | P00004 | $0 | THIS MODIFICATION IS ISSUED TO UPDATE THE TERMS OF THE CRF PAYMENT REMITTAL AND SUBMISSION OF QUARTERLY SALES REPORTS. |
| Feb 1, 2024 | P00003 | $0 | EXERCISE THE FIRST OPTION YEAR WITH NO PRICE CHANGES (PERIOD OF PERFORMANCE 2/19/2024 - 2/18/2025) |
| May 15, 2023 | P00002 | $0 | INCORPORATE DSCSA LANGUAGE |
| Feb 16, 2023 | P00001 | $0 | INCORPORATE 5 NDC CHANGES (FOR THE 500 COUNT BOTTLES) |
| Dec 6, 2022 | 0 | $0 | 10 LINE ITEMS FOR DOXEPIN CAPSULES. AWARDED FOR BASE YEAR 2/19/2023 TO 2/18/2024 PLUS 4 ONE-YEAR OPTIONS. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.